James E. Fickenscher
Overview
James E. Fickenscher received an average of $1M in total compensation, including $359K in salary, at Zynerba Pharmaceuticals from 2016 to 2022. James Fickenscher also received an average of $685K at Antares Pharma between 2014 and 2015.
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Zynerba PharmaceuticalsCFO and VP, Corporate Development
Zynerba PharmaceuticalsCFO and VP, Corporate Development
Zynerba PharmaceuticalsCFO and VP, Corporate Development
Zynerba PharmaceuticalsChief Financial Officer and Vice President, Corporate Development
Zynerba PharmaceuticalsChief Financial Officer and Vice President, Corporate Development
Zynerba PharmaceuticalsChief Financial Officer and Vice President, Corporate Development
Zynerba PharmaceuticalsChief Financial Officer and Vice President, Corporate Development
Antares PharmaChief Financial Officer
Antares PharmaChief Financial Officer
Source: SEC filings on April 21, 2023, April 25, 2022, April 21, 2021, April 23, 2020, April 25, 2019, April 23, 2018, and April 22, 2016.
Related executives
We found 15 more executives who work or worked at Zynerba Pharmaceuticals and Antares Pharma.
Armando Anido
Zynerba Pharmaceuticals
Chief Executive Officer
Terri Sebree
Zynerba Pharmaceuticals
President
Robert Apple
Antares Pharma
Chief Executive Officer
Fred Powell
Antares Pharma
Chief Financial Officer
Peter Graham
Antares Pharma
General Counsel
James Tursi
Antares Pharma
Chief Medical Officer
Eamonn Hobbs
Antares Pharma
Chief Executive Officer
Richard Baron
Zynerba Pharmaceuticals
Chief Financial Officer
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019